🔴 Pacific Biosciences is trading 10.2% down with no identified company catalyst

Pacific Biosciences is trading 10.2% down now at $1.76, with no clear company-specific announcement explaining the October 16 drop.

• MarketWatch also reported no identified company catalyst for the decline.
• XBI was down 2.06%, while the Nasdaq was down 1.23% in the supplied market context; Pacific Biosciences’ decline was substantially sharper.
• The available evidence does not establish a more specific trigger.